Skip to content
Rolls-Royce introduces new business jet powered by 100% SAF
Rolls-Royce and Gulfstream Aerospace Corp. are conducting the first original equipment manufacturer test ...
Read More
HHS: Alzheimer’s risk linked to systemic racism
Racism and inequities are among the key reasons behind the relatively high rates ...
Read More
Our Top 15 Most-Clicked Stories of 2022
Thanks for joining us in Year 1 of Bio.News. We published over 700 ...
Read More
Updated COVID boosters slash hospitalization risk by 50%
The Centers for Disease Control and Prevention (CDC) said updated COVID-19 booster vaccines ...
Read More
FDA approves first monoclonal antibody to treat COVID-19
The U.S. Food and Drug Administration (FDA) approved Genentech’s Actemra to treat COVID-19 ...
Read More
What’s happening with the COVID IP waiver expansion?
The United States and the Biotechnology Innovation Organization (BIO) have been taking action ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...
Federal Policy
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and runs through Dec. 7. “As patient advocates have seen year after ...
BIO Events
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11 BIO ...
BIO Events
Ahead of BIO IP Conference, research highlights why biotech needs strong patents
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship between ...
BIO Events
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts on ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures ...
Read More
International
Bio's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely ...
Read More
